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Edited by Peter BrzezinskiAbstract The term orthodisease has recently been introduced
to deﬁne human disorders in which the pathogenic gene has
orthologs in model organism genomes. Here, we describe
Hailey–Hailey disease (HHD), a blistering skin disorder caused
by haploinsuﬃciency of ATP2C1 as an orthodisease from a
Saccharomyces cerevisiae perspective. ATP2C1 encodes the
human secretory pathway Ca2+/Mn2+ ATPase hSPCA1 and is
orthologous to the PMR1 gene in S. cerevisiae. hSPCA1 fully
complements PMR1 deﬁciency in yeast and pmr1DS. cerevisiae
has proved to be a valuable tool to screen ATP2C1 mutations
and address potential pathogenic/pharmacologic mechanisms
in HHD. Consequently, this human skin disorder is an ideal
example of an orthodisease.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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One of the most important goals of genome sequencing pro-
jects is to enhance our understanding of human disorders and
to support the development of potential therapies. These pro-
jects have revealed that many of the genes identiﬁed in genetic
model organisms share a common ancestry and function with
human genes. This is particularly true for orthologs. Orthologs
are genes in divergent species that have originated from a sin-
gle gene in the last shared ancestor [1]. The genes mutated in
human disease which have an ortholog in common model
organisms tend to be those involved in basic cellular processes
such as metabolism and cellular control [2]. This is true for the
290 human orthologs found in the versatile genetic model
organism Saccharomyces cerevisiae. One ideal example is the
S. cerevisiae PMR1 gene [3]. It is orthologous to ATP2C1,
the gene encoding the human secretory pathway Ca2+/Mn2+
ATPase, hSPCA1 mutated in Hailey–Hailey disease (HHD)
[4,5]. Here, we review HHD from a S. cerevisiae perspective
and show the beneﬁt of utilizing this microbe as a genetic
model organism.*Fax: +36 72 535 972.
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Hailey–Hailey disease (MIM# 169600) or benign familial
pemphigus was ﬁrst described by the Hailey brothers in 1939
[6]. It is an autosomal dominant blistering skin disorder man-
ifesting in the 3rd to 4th decades of life with an incidence of 1
in 50 thousand. Vesicular itchy painful lesions on an erythem-
atous base characterize the rash. The lesions most commonly
aﬀect the ﬂexural areas of the skin. Friction, sweating, UV
exposure and cutaneous infections trigger the rash. The disease
has a ﬂuctuating course with remissions and exacerbations.
Penetrance in adults is complete but expressivity is variable
[7]. In rare instances, the rash may become generalized [8,9]
and the skin lesions may even develop into squamous cell car-
cinoma [10,11]. There are no extracutaneous manifestations of
the disorder.
Histopathology of the skin lesions shows a widespread loss
of cell-to-cell adhesion (acantholysis) in the suprabasal layer
of the epidermis. Ultrastructural studies demonstrate perinu-
clear aggregation of keratin intermediate ﬁlaments, which have
retracted from the desmosomal plaques in the acantholytic
cells [12,13].
In 2000 two separate research groups have linked HHD to
mutations to ATP2C1, the gene encoding the human secretory
pathway Ca2+/Mn2+ ATPase hSPCA1 [4,5].
2.1. ATP2C1
The ATP2C1 gene comprises 28 exons in an 30 kb segment
of chromosome 3q21. It encodes a 4.5 kb transcript that is
alternatively spliced into 4 variants, ATP2C1a-to-d [4,5,14–
16]. ATP2C1d is the largest variant containing the entire exons
27 and 28 [17]. It is unknown whether there are functional dif-
ferences between these splice-isoforms.
The ATP2C1 encoded hSPCA1 belongs to the SPCA sub-
family of P-type ion motive ATPases. SPCA pumps possess
only one of the two high-aﬃnity Ca2+ binding sites characteris-
tic of SERCA (sarco/endoplasmatic-reticulum Ca2+-transport
ATPases). However, they can transport a single Ca2+- or
Mn2+-ion per cycle with high eﬃciency. These characteristics
separate SPCA from the P-type SERCA and PMCA (plasma-
membrane Ca2+) pumps [18,19].
hSPCA1 is ubiquitously expressed in human tissues but to
varying degrees with the greatest abundance in keratinocytes
[4]. hSPCA1 localizes to the Golgi-apparatus and controls its
Ca2+ stores along with SERCA transporters. The contribution
of hSPCA1 to the total Ca2+ uptake of the Golgi varies amongblished by Elsevier B.V. All rights reserved.
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cytes, the role of SPCA1 is even more signiﬁcant [20–22]. This
in part may explain why only the skin is aﬀected in HHD,
although the exact reason for this phenomenon is currently
not well understood [23,24].
While hSPCA1 is mostly localized to the Golgi, it detectably
contributes to ﬁlling up ER Ca2+ stores in certain cell types
and has been shown to exert eﬀects on both Golgi and
ER function such as post-translational glycan processing, ER
associated protein degradation (ERAD) and response to ER
stress [25,26]. hSPCA1 also appears to be important in ﬁne
tuning cytosolic Ca2+ oscillations [18,21,25]. HHD keratino-
cytes have elevated cytosolic Ca2+ levels but accumulate less
Ca2+ overall than normal keratinocytes. Additionally, HHD
keratinocytes are less responsive to increasing levels of extra-
cellular calcium than their normal counterparts [4].
To date more than 80 diﬀerent mutations in ATP2C1 have
been reported in HHD. Among these 20% are nonsense muta-
tions, 19% are splice site mutations, 30% are frameshift muta-
tions leading to premature termination codons (PTC), 28% are
missense mutations, and 3% are in-frame deletions or inser-
tions [23,24]. The high number of mutations leading to PTC
pointed to haploinsuﬃciency as the prevalent mechanism for
the dominant inheritance of HHD. Studies on missense muta-
tions aﬀecting protein stability and function have shown that
while mutant ATP2C1 mRNA levels are normal, the level of
the defective protein is lower than that of the wild type despite
correct targeting to the Golgi. These observations lent further
support for haploinsuﬃciency as the primary mechanism for
the dominant inheritance of HHD and revealed a crucial role
for Asp742 and Gly309 in the binding of Ca
2+ and/or Mn2+ to
hSPCA1 (Fig. 1) [17,27]. Despite of our broadening under-
standing about hSPCA1 structure and function, most of our
knowledge of SPCA pumps comes from the S. cerevisiae
homolog, PMR1.
2.2. PMR1
PMR1 was the ﬁrst member of the SPCA pumps to be iden-
tiﬁed [3,28]. It localizes mainly to the medial Golgi but is also
responsible for maintaining ER Ca2+/Mn2+ homeostasis alongFig. 1. Major residues of SPCA transporters. Transmembrane helices
M4, M5 and M6 are critical for ion selectivity and transport.
Mutations V335Q and Q783A appear to inﬂuence conformation-
sensitive helix packing at the membrane interface and aﬀect ion
selectivity [38,39]. Mutations G309C and D742Y also alter Ca2+ and/
or Mn2+ binding to hSPCA1 [17,27]. The major cytoplasmic loop
constitutes the phosphorylation and nucleotide binding domains.with another P-type ATPase, COD1 in S. cerevisiae [29,30].
PMR1 defective yeast strains are sensitive to both low levels
of divalent cations (EGTA, BAPTA treatment) and high levels
of calcium in the extracellular environment [31–33]. They pos-
sess elevated levels of cytosolic and total cellular calcium [33].
Pmr1D strains are also susceptible to manganese and oxidative
stress but are tolerant to Na+ [34–36]. Due to a perturbed ER
and Golgi Ca2+/Mn2+ homeostasis, pmr1DS. cerevisiae are
defective in protein processing through the secretory pathway
and are sensitive to ER stress [29,30,37]. Mutational analyses
of PMR1 deﬁned Gln783 as a critical residue for Mn
2+ selectiv-
ity and revealed an important role for packaging interactions
between transmembrane helices in the protein (Fig. 1)
[38,39]. The recognition that the human homolog of PMR1
is aﬀected in HHD inspired yeast researchers to utilize this
powerful model organism in exploring the pathophysiology
and potential therapy of this genodermatosis [40,41].3. Hailey–Hailey disease from a S. cerevisiae perspective
Although hSPCA1 shares only 49% homology with PMR1,
it fully complements the BAPTA/EGTA and the Mn2+ sensi-
tive phenotype of PMR1 defective yeast [42]. This recognition
has prompted experiments in which a pmr1D strain expressing
hSPCA1 mutants was found to be a valuable functional
screening tool for hSPCA1 defects [43]. Additionally, missense
HHD mutations transformed into WT yeast did not confer
hypersensitivity to BAPTA or Mn2+, which observation sup-
ports haploinsuﬃciency as the primary mechanism for autoso-
mal dominant inheritance in this disorder. Another study on
PMR1 defective S. cerevisiae addressed the possible beneﬁcial
eﬀects of calcineurin inhibition in HHD. It was shown that cal-
cineurin inhibition alleviates only the high calcium sensitive
phenotype of pmr1D [44]. Indeed, hSPCA1 complements the
high Ca2+ sensitive phenotype of pmr1D yeast. Additionally,
PMR1 defective yeast are less responsive in accumulating cal-
cium upon elevations of extracellular Ca2+ thanWT, much like
HHD keratinocytes (unpublished results). These observations
indicate that the high calcium sensitive phenotype of PMR1
defective yeast may be the most relevant in resembling HHD
keratinocyte pathology. Moreover, the ﬁndings propose that
the defective high calcium response of HHD keratinocytes
may be an important feature in the pathogenesis of this disor-
der. Yet, a recent study has shown that hSPCA1 immunoﬂuo-
rescence signiﬁcantly decreases upon elevation of extracellular
Ca2+ levels in various human cell lines [26]. However, it was
not taken into consideration that Western blot and functional
experiments in keratinocytes point to an increasing role of
hSPCA1 upon extracellular calcium challenge [4,22]. These
seemingly contradictory results remain to be clariﬁed.
It has been discussed earlier that hSPCA1 controls ER and
Golgi Ca2+/Mn2+ levels to varying degrees in non-epidermal
cells. Yet, only the skin is aﬀected in HHD, the reason of which
is currently not well understood. Indeed hSPCA1 depletion en-
hances calcium dependent glucose-induced insulin secretion in
pancreatic cells [25], but alterations in carbohydrate metabo-
lism is not a feature of HHD. Similarly, PMR1 defective yeast
have an exaggerated cytosolic calcium response upon glucose
readdition to starved cells [45], however, this does not manifest
in any obvious correlating phenotype.
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visiae point to defective calcium handling upon high calcium
challenge as being an important pathogenic feature of HHD
and that the skin may be particularly sensitive in this respect.
Interestingly, a unique Ca2+ gradient is present in the healthy
epidermis with lowest calcium levels in the basal layer and
highest in the granular layer of the skin both intra and extra-
cellularly (Fig. 2A). This gradient appears to be a key element
for the diﬀerentiation process in the epidermis through a coun-
ter-talk between keratinocytes and the extracellular space in
which the calcium sensing receptor (CaR) is an important
player [46,47]. Indirect observations on PMR1 defective yeast
have lead to the conclusion that a similar type of extracellular
calcium sensing is an important component of the cellular cal-
cium homeostasis in S. cerevisiae also [32].
The epidermal calcium gradient dissipates upon perturba-
tions in the permeability barrier of the skin (i.e., noxious stim-
uli) and is restored to normal within 6–24 h under ideal
conditions (Fig. 2A) [48]. During this repair process there is
a small overshoot where Ca2+ concentrations in the spinous
layers actually increase to a level slightly higher than the pre-Fig. 2. The absence of the epidermal Ca2+ gradient potentially
promotes suprabasal acantholysis in HHD. (A) The epidermal Ca2+
gradient dissipates upon noxious stimuli that disrupt the epidermal
permeability barrier in normal skin. (B1) This process potentially
reinforces cell-to-cell adhesion in the lower layers of the epidermis by a
direct, post-translational eﬀect of extracellular Ca2+ elevation that
stabilizes desmosomal integrity. The elevated level of extracellular
calcium likely induces CaR mediated processes, which at least in part
aﬀect ER/Golgi Ca2+ homeostasis [55] and potentially further support
cell-to-cell adhesion. (B2) In HHD epidermis, however, the epidermal
Ca2+ gradient is absent. Consequently, the increase of extracellular
Ca2+ in the suprabasal layer (SBL) of the epidermis does not occur. In
the absence of appropriate levels of Ca2+ to reinforce desmosomal
connections the cells loose their cell-to-cell adhesion and acantholysis
ensues. Additionally, the CaR activation is decreased and/or the
subsequent changes in the ER/Golgi Ca2+ homeostasis are defective
due to lower amounts of hSPCA1 and consequently decreased levels of
Ca2+ and Mn2+ in these compartments. HHD, Hailey–Hailey disease;
SBL, suprabasal layer; CaR, calcium sensing receptor.ceding resting level [49,50]. These processes may be important
for the skin in the response to optimize recovery from stress.
HHD epidermis is devoid of a calcium gradient even in the
intact areas of the skin. This is likely due to the inability of
HHD keratinocytes to accumulate calcium properly upon
increasing extracellular levels of Ca2+. While total calcium lev-
els are signiﬁcantly decreased in the granular layer of the epi-
dermis in HHD skin, the basal and suprabasal layers contain
similar amounts of calcium as the epidermis in normal skin
[4]. This is also true for cellular ATP levels [51]. These obser-
vations argue that the primary defect in HHD skin is the de-
creased amount of total calcium in the granular layer of the
epidermis. However, it is the suprabasal keratinocytes that suf-
fer from desmosomal disruption leading to acantholysis upon
exacerbating noxious stimuli. Surprisingly enough, extracellu-
lar Ca2+ increase can stimulate desmosome formation in kerat-
inocytes previously exposed to low Ca2+ environment within
minutes of the shift arguing for a direct post-translational ef-
fect of calcium in this process [52,53]. HHD keratinocytes have
normal amounts of desmosomal proteins that can bind other
proteins with the same eﬃciency as seen in normal epidermal
cells. Desmosome formation and response to noxious UVB
irradiation are also similar in monolayer HHD and normal
keratinocyte cultures [54]. These observations indicate that
the unique environment of the whole epidermis is required
for the manifestation of detectable abnormalities in HHD
keratinocyte desmosome assembly.
Based on the above ﬁndings, we propose that the absence of
the unique epidermal Ca2+ gradient is a key pathogenic feature
of HHD. Without the normal response of Ca2+-gradient-dis-
ruption and the subsequent elevation of extracellular calcium
in the lower layers of the epidermis HHD keratinocytes in
the suprabasal layer are incapable of reinforcing the desmo-
somal connections necessary to maintain epidermal integrity
following noxious stimuli and loose their cell-to-cell connec-
tions (Fig. 2B). This process may at least in part be responsible
for acantholysis, the hallmark of the disorder. Indeed, if this
assumption was true it would explain why the characteristic
rash of HHD exacerbates upon noxious stimulation (i.e., epi-
dermal barrier disruption).
In addition to causing a looser cell-to-cell adhesion directly,
the low Ca2+ response in the suprabasal layer following noxious
stimulation may lead to a decreased CaR mediated signaling
processes that may inﬂuence the regeneration of keratinocyte
cell-to-cell adhesion. Alternatively, CaR dependent signaling
events may be unaﬀected, but as a result of defective ER and
Golgi Ca2+ homeostasis (due to the decreased amount of
hSPCA1) the disrupted downstream elements of the cascade
may hamper epidermal regeneration. Naturally, the latter two
mechanisms may even simultaneously aﬀect the stress response
of the suprabasal skin layer (Fig. 2B). Therefore, it is very likely
that the cellular (decreased CaR response and/or defective pro-
tein processing in the ER/Golgi apparatus) and the whole tissue
(absent Ca2+ gradient) defects of the epidermis are cooperatively
responsible for the manifestation of HHD in the skin.4. Conclusion
The compact genome of S. cerevisiae and the ease of genetic
and molecular manipulations with it have turned this microbe
into a powerful model organism. This review clearly
2024 R. Kellermayer / FEBS Letters 579 (2005) 2021–2025demonstrates the beneﬁt of utilizing, S. cerevisiae in elucidat-
ing the pathogenesis and potential therapy of human disorders
such as HHD.
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